Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub

The FDA's Role in Gene TherapyПодробнее

FDA Rare Disease Day 2023: “Intersections with Rare Diseases – A patient focused event”Подробнее

Cure GM1 Public Comment at the Inaugural Rare Disease Innovation Hub Meeting on 10/16/2024Подробнее

Rare Disease Through a Different LensПодробнее

OHC 2023 Rare Disease Day Webinar: Advancing Novel Therapies for Rare DiseasesПодробнее

FDA Efforts to Advance Medical Product Development for Rare DiseasesПодробнее

Advancing Rare Disease Breakthroughs at Mayo ClinicПодробнее

FDA's Rare Disease Day 2024—Dedicated to Patients and ProvidersПодробнее

Advancing innovation in genomic medicine for rare diseasesПодробнее

Dina Zand's Work on Rare DiseasesПодробнее

Patients Matter: How Rare Disease Patients Can Move Scientific Discovery ForwardПодробнее

Strategies for Advancing APBD and Rare Disease Research - A Conversation with the NIH and the FDAПодробнее

Governments Spur Rare Disease Treatments - Part 1Подробнее

Dr. Janet Maynard Recognizes Successes and Continued Need for Rare Disease Research GrantsПодробнее

Pioneering Rare Disease Therapies: 2024 Rare Disease Day Webinar HighlightsПодробнее

Lucas Kempf, MD: FDA and Rare Disease TherapiesПодробнее

Rare Diseases are Not Rare – A Training on Rare Disease ResourcesПодробнее

Rare Diseases: The Path Less Chosen - Boston Children's Hospital | Innovation Summit 2014Подробнее

Fast-Tracking Hope: FDA's Bold MOVE to Propel Rare Disease Therapies!Подробнее